Gene Review:
F10 - coagulation factor X
Homo sapiens
Synonyms:
Coagulation factor X, FX, FXA, Stuart factor, Stuart-Prower factor
- Molecular analysis of the genotype-phenotype relationship in factor X deficiency. Millar, D.S., Elliston, L., Deex, P., Krawczak, M., Wacey, A.I., Reynaud, J., Nieuwenhuis, H.K., Bolton-Maggs, P., Mannucci, P.M., Reverter, J.C., Cachia, P., Pasi, K.J., Layton, D.M., Cooper, D.N. Hum. Genet. (2000)
- Isolation and characterisation of vascular endothelial growth factor-165 specific scFv fragments by phage display. Smith, K.A., Kirkpatrick, N., Madden, L.A., Topping, K.P., Monson, J.R., Greenman, J. Int. J. Oncol. (2003)
- Establishment of functional human pituitary tumor cell cultures. Melmed, S., Odenheimer, D., Carlson, H.E., Hershman, J.M. In vitro. (1982)
- Thrombin-activable factor X re-establishes an intrinsic amplification in tenase-deficient plasmas. Louvain-Quintard, V.B., Bianchini, E.P., Calmel-Tareau, C., Tagzirt, M., Le Bonniec, B.F. J. Biol. Chem. (2005)
- Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Bogdanov, V.Y., Balasubramanian, V., Hathcock, J., Vele, O., Lieb, M., Nemerson, Y. Nat. Med. (2003)
- Prostacyclin stimulation of the activation of blood coagulation factor X by platelets. Dutta-Roy, A.K., Ray, T.K., Sinha, A.K. Science (1986)
- A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. Ito, A., Katoh, F., Kataoka, T.R., Okada, M., Tsubota, N., Asada, H., Yoshikawa, K., Maeda, S., Kitamura, Y., Yamasaki, H., Nojima, H. J. Clin. Invest. (2000)
- Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus binding. Livingston, J.R., Sutherland, M.R., Friedman, H.M., Pryzdial, E.L. Biochem. J. (2006)
- Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis. Imamura, T., Potempa, J., Tanase, S., Travis, J. J. Biol. Chem. (1997)
- gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver. Obrador, E., Carretero, J., Ortega, A., Medina, I., Rodilla, V., Pellicer, J.A., Estrela, J.M. Hepatology (2002)
- Molecular basis for thymidine modulation of the efficacy and toxicity of alkylating agents. Hwu, W.J., Mozdziesz, D.E. Pharmacol. Ther. (1997)
- Blood coagulation factors in human embryonic-fetal development: preferential expression of the FVII/tissue factor pathway. Hassan, H.J., Leonardi, A., Chelucci, C., Mattia, G., Macioce, G., Guerriero, R., Russo, G., Mannucci, P.M., Peschle, C. Blood (1990)
- Substrate recognition by tissue factor-factor VIIa. Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X. Huang, Q., Neuenschwander, P.F., Rezaie, A.R., Morrissey, J.H. J. Biol. Chem. (1996)
- Impaired prothrombinase activity of factor X Gly381Asp results in severe familial CRM+ FX deficiency. Pinotti, M., Camire, R.M., Baroni, M., Rajab, A., Marchetti, G., Bernardi, F. Thromb. Haemost. (2003)
- O, K, H and fimbrial antigens in Escherichia coli serotypes associated with pyelonephritis and cystitis. Orskov, I., Orskov, F., Birch-Andersen, A., Kanamori, M., Svanborg-Edén, C. Scandinavian journal of infectious diseases. Supplementum. (1982)
- Cloning and expression in COS-1 cells of a full-length cDNA encoding human coagulation factor X. Messier, T.L., Pittman, D.D., Long, G.L., Kaufman, R.J., Church, W.R. Gene (1991)
- The effects of aging on tumor growth and angiogenesis are tumor-cell dependent. Reed, M.J., Karres, N., Eyman, D., Cruz, A., Brekken, R.A., Plymate, S. Int. J. Cancer (2007)
- Progesterone production by luteal cells isolated from cynomolgus monkeys: effects of gonadotropin and prolactin during acute incubation and cell culture. Stouffer, R.L., Coensgen, J.L., Hodgen, G.D. Steroids (1980)
- Mouse embryo culture for screening in human IVF. Ackerman, S.B., Taylor, S.P., Swanson, R.J., Laurell, L.H. Arch. Androl. (1984)
- High-resolution NMR studies of fibrinogen-like peptides in solution: resonance assignments and conformational analysis of residues 1-23 of the A alpha chain of human fibrinogen. Ni, F., Scheraga, H.A., Lord, S.T. Biochemistry (1988)
- Interaction of the A1 subunit of factor VIIIa and the serine protease domain of factor X identified by zero-length cross-linking. Lapan, K.A., Fay, P.J. Thromb. Haemost. (1998)
- Prediction of changes in levels of haemostatic variables during natural menstrual cycle and ovarian hyperstimulation. Andersson, O., Blombäck, M., Bremme, K., Wramsby, H. Thromb. Haemost. (1997)
- Binding of plasminogen and tissue plasminogen activator to plasmin-modulated factor X and factor Xa. Grundy, J.E., Lavigne, N., Hirama, T., MacKenzie, C.R., Pryzdial, E.L. Biochemistry (2001)
- The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor. Zhong, D., Bajaj, M.S., Schmidt, A.E., Bajaj, S.P. J. Biol. Chem. (2002)
- Structural and functional characterization of platelet receptor-mediated factor VIII binding. Ahmad, S.S., Scandura, J.M., Walsh, P.N. J. Biol. Chem. (2000)
- Plasmin converts factor X from coagulation zymogen to fibrinolysis cofactor. Pryzdial, E.L., Lavigne, N., Dupuis, N., Kessler, G.E. J. Biol. Chem. (1999)
- Synthesis and characterization of wild-type and variant gamma-carboxyglutamic acid-containing domains of factor VII. Martin, D.M., O'Brien, D.P., Tuddenham, E.G., Byfield, P.G. Biochemistry (1993)
- The relative orientation of Gla and EGF domains in coagulation factor X is altered by Ca2+ binding to the first EGF domain. A combined NMR-small angle X-ray scattering study. Sunnerhagen, M., Olah, G.A., Stenflo, J., Forsén, S., Drakenberg, T., Trewhella, J. Biochemistry (1996)
- Anticoagulant potential of an antibody against factor VII. Chu, A.J., Mathews, S.T. J. Surg. Res. (2003)
- Protease-activated receptor-2 expression in IgA nephropathy: a potential role in the pathogenesis of interstitial fibrosis. Grandaliano, G., Pontrelli, P., Cerullo, G., Monno, R., Ranieri, E., Ursi, M., Loverre, A., Gesualdo, L., Schena, F.P. J. Am. Soc. Nephrol. (2003)
- Protamine inhibits tissue factor-initiated extrinsic coagulation. Chu, A.J., Wang, Z.G., Raicu, M., Beydoun, S., Ramos, N. Br. J. Haematol. (2001)
- Gene therapy for experimental brain tumors using a xenogenic cell line engineered to secrete hIL-2. Lesniak, M.S., Tyler, B.M., Pardoll, D.M., Brem, H. J. Neurooncol. (2003)
- Effect of sulphated polysaccharides on the alpha 1-antitrypsin inhibition of amidolysis catalysed by coagulation cascade proteinases. Long, W.F., Williamson, F.B. Br. J. Pharmacol. (1981)
- Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Camerer, E., Huang, W., Coughlin, S.R. Proc. Natl. Acad. Sci. U.S.A. (2000)
- Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency. Pinotti, M., Marchetti, G., Baroni, M., Cinotti, F., Morfini, M., Bernardi, F. Thromb. Haemost. (2002)
- Studies on the blood clotting and fibrinolytic system in the plasma from a sei (baleen) whale. Saito, H., Poon, M., Goldsmith, G.H., Ratnoff, O.D., Arnason, U. Proc. Soc. Exp. Biol. Med. (1976)
- Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells. Jiang, X., Guo, Y.L., Bromberg, M.E. Thromb. Haemost. (2006)
- Effects of high-dose methylprednisolone therapy on coagulation factors in patients with acute immune thrombocytopenic purpura. Oner, A.F., Bay, A., Kuru, M., Uner, A., Arslan, S., Caksen, H. Clin. Appl. Thromb. Hemost. (2005)